234 related articles for article (PubMed ID: 30376853)
1. Recurrent maternal virilization during pregnancy in patients with PCOS: two clinical cases.
Deknuydt M; Dumont A; Bruyneel A; Dewailly D; Catteau-Jonard S
Reprod Biol Endocrinol; 2018 Oct; 16(1):107. PubMed ID: 30376853
[TBL] [Abstract][Full Text] [Related]
2. Recurrent maternal virilization during pregnancy associated with polycystic ovarian syndrome: a case report and review of the literature.
Ben-Chetrit A; Greenblatt EM
Hum Reprod; 1995 Nov; 10(11):3057-60. PubMed ID: 8747073
[TBL] [Abstract][Full Text] [Related]
3. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
Ravi SJ; Cree-Green M
J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
[TBL] [Abstract][Full Text] [Related]
4. Non-PCOS Hyperandrogenic Disorders in Adolescents.
Esquivel-Zuniga MR; Kirschner CK; McCartney CR; Burt Solorzano CM
Semin Reprod Med; 2022 Mar; 40(1-02):42-52. PubMed ID: 35052005
[TBL] [Abstract][Full Text] [Related]
5. [Hyperandrogenism and pregnancy].
Thorin-Savouré A; Kuhn JM
Ann Endocrinol (Paris); 2002 Oct; 63(5):443-51. PubMed ID: 12442087
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
7. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
8. Hyperandrogenic states in pregnancy.
Kaňová N; Bičíková M
Physiol Res; 2011; 60(2):243-52. PubMed ID: 21114372
[TBL] [Abstract][Full Text] [Related]
9. Approach to androgen excess in women: Clinical and biochemical insights.
Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
[TBL] [Abstract][Full Text] [Related]
10. Maternal hyperandrogenism beginning from early pregnancy and progressing until delivery does not produce virilization of a female newborn.
Bertalan R; Csabay L; Blazovics A; Rigo J; Varga I; Halasz Z; Toldy E; Boyle B; Racz K
Gynecol Endocrinol; 2007 Oct; 23(10):581-3. PubMed ID: 17852424
[TBL] [Abstract][Full Text] [Related]
11. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
12. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy complications in women with polycystic ovary syndrome.
Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
[TBL] [Abstract][Full Text] [Related]
14. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
15. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
Rachoń D
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
[TBL] [Abstract][Full Text] [Related]
17. Recurrent severe hyperandrogenism during pregnancy: a case report.
Holt HB; Medbak S; Kirk D; Guirgis R; Hughes I; Cummings MH; Meeking DR
J Clin Pathol; 2005 Apr; 58(4):439-42. PubMed ID: 15790717
[TBL] [Abstract][Full Text] [Related]
18. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
20. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
Xita N; Tsatsoulis A
J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
